Vosoughi Pegah, Naghib Seyed Morteza, Rahmanian Mehdi, Mozafari M R
Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, 1684613114, Iran.
Biomaterials and Tissue Engineering Research Group, Interdisciplinary Technologies Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Curr Top Med Chem. 2025;25(12):1467-1491. doi: 10.2174/0115680266325847241121034100.
Ongoing research and development efforts are currently focused on creating COVID-19 vaccines using a variety of platforms. Among these, mRNA technology stands out as a cuttingedge method for vaccine development. There is a growing public awareness of mRNA and its potential in vaccine development. Despite being relatively recent, extensive scientific research has been dedicated to vaccines for a considerable period. mRNA vaccines are created by synthesizing the spike protein from a DNA template. This review delves into the various aspects of these vaccines and thoroughly explores the intricacies of COVID-19 vaccinations. It is essential to choose a reliable, efficient, and widely accessible vaccine to combat COVID-19. However, due to the possibility of virus mutations, developing a dependable and safe vaccine is crucial to prepare for future outbreaks of SARS-CoV-2 variants. Meanwhile, concerns remain regarding the potential risks associated with these vaccines.
目前正在进行的研发工作主要集中在利用多种平台研发新冠疫苗。其中,mRNA技术作为一种前沿的疫苗研发方法脱颖而出。公众对mRNA及其在疫苗研发中的潜力的认识正在不断提高。尽管mRNA技术相对较新,但长期以来已有大量科学研究致力于疫苗研发。mRNA疫苗是通过从DNA模板合成刺突蛋白而制成的。本综述深入探讨了这些疫苗的各个方面,并全面探究了新冠疫苗接种的复杂性。选择一种可靠、高效且广泛可得的疫苗来对抗新冠病毒至关重要。然而,由于病毒可能发生变异,研发一种可靠且安全的疫苗对于应对未来新冠病毒变异株的爆发至关重要。与此同时,人们对这些疫苗的潜在风险仍存在担忧。